Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

Cathrine Axfors; Andreas M Schmitt; Perrine Janiaud; Janneke Van't Hooft; Sherief Abd-Elsalam; Ehab F Abdo; Benjamin S Abella; Javed Akram; Ravi K Amaravadi; Derek C Angus; Yaseen M Arabi; Shehnoor Azhar; Lindsey R Baden; Arthur W Baker; Leila Belkhir; Thomas Benfield; Marvin A H Berrevoets; Cheng-Pin Chen; Tsung-Chia Chen; Shu-Hsing Cheng; Chien-Yu Cheng; Wei-Sheng Chung; Yehuda Z Cohen; Lisa N Cowan; Olav Dalgard; Fernando F de Almeida E Val; Marcus V G de Lacerda; Gisely C de Melo; Lennie Derde; Vincent Dubee; Anissa Elfakir; Anthony C Gordon; Carmen M Hernandez-Cardenas; Thomas Hills; Andy I M Hoepelman; Yi-Wen Huang; Bruno Igau; Ronghua Jin; Felipe Jurado-Camacho; Khalid S Khan; Peter G Kremsner; Benno Kreuels; Cheng-Yu Kuo; Thuy Le; Yi-Chun Lin; Wu-Pu Lin; Tse-Hung Lin; Magnus Nakrem Lyngbakken; Colin McArthur; Bryan J McVerry; Patricia Meza-Meneses; Wuelton M Monteiro; Susan C Morpeth; Ahmad Mourad; Mark J Mulligan; Srinivas Murthy; Susanna Naggie; Shanti Narayanasamy; Alistair Nichol; Lewis A Novack; Sean M O'Brien; Nwora Lance Okeke; Léna Perez; Rogelio Perez-Padilla; Laurent Perrin; Arantxa Remigio-Luna; Norma E Rivera-Martinez; Frank W Rockhold; Sebastian Rodriguez-Llamazares; Robert Rolfe; Rossana Rosa; Helge Røsjø; Vanderson S Sampaio; Todd B Seto; Muhammad Shahzad; Shaimaa Soliman; Jason E Stout; Ireri Thirion-Romero; Andrea B Troxel; Ting-Yu Tseng; Nicholas A Turner; Robert J Ulrich; Stephen R Walsh; Steve A Webb; Jesper M Weehuizen; Maria Velinova; Hon-Lai Wong; Rebekah Wrenn; Fernando G Zampieri; Wu Zhong; David Moher; Steven N Goodman; John P A Ioannidis; Lars G Hemkens

doi:10.1038/s41467-024-45360-6

Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

Cathrine Axfors, Andreas M Schmitt, Perrine Janiaud, Janneke Van't Hooft, Sherief Abd-Elsalam, Ehab F Abdo, Benjamin S Abella, Javed Akram, Ravi K Amaravadi, Derek C Angus, Yaseen M Arabi, Shehnoor Azhar, Lindsey R Baden, Arthur W Baker, Leila Belkhir, Thomas Benfield, Marvin A H Berrevoets, Cheng-Pin Chen, Tsung-Chia Chen, Shu-Hsing ChengChien-Yu Cheng, Wei-Sheng Chung, Yehuda Z Cohen, Lisa N Cowan, Olav Dalgard, Fernando F de Almeida E Val, Marcus V G de Lacerda, Gisely C de Melo, Lennie Derde, Vincent Dubee, Anissa Elfakir, Anthony C Gordon, Carmen M Hernandez-Cardenas, Thomas Hills, Andy I M Hoepelman, Yi-Wen Huang, Bruno Igau, Ronghua Jin, Felipe Jurado-Camacho, Khalid S Khan, Peter G Kremsner, Benno Kreuels, Cheng-Yu Kuo, Thuy Le, Yi-Chun Lin, Wu-Pu Lin, Tse-Hung Lin, Magnus Nakrem Lyngbakken, Colin McArthur, Bryan J McVerry, Patricia Meza-Meneses, Wuelton M Monteiro, Susan C Morpeth, Ahmad Mourad, Mark J Mulligan, Srinivas Murthy, Susanna Naggie, Shanti Narayanasamy, Alistair Nichol, Lewis A Novack, Sean M O'Brien, Nwora Lance Okeke, Léna Perez, Rogelio Perez-Padilla, Laurent Perrin, Arantxa Remigio-Luna, Norma E Rivera-Martinez, Frank W Rockhold, Sebastian Rodriguez-Llamazares, Robert Rolfe, Rossana Rosa, Helge Røsjø, Vanderson S Sampaio, Todd B Seto, Muhammad Shahzad, Shaimaa Soliman, Jason E Stout, Ireri Thirion-Romero, Andrea B Troxel, Ting-Yu Tseng, Nicholas A Turner, Robert J Ulrich, Stephen R Walsh, Steve A Webb, Jesper M Weehuizen, Maria Velinova, Hon-Lai Wong, Rebekah Wrenn, Fernando G Zampieri, Wu Zhong, David Moher, Steven N Goodman, John P A Ioannidis, Lars G Hemkens^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Downloads (Pure)

Abstract

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-021-22446-z, published online 15 April 2021 The original version of this article contained an error in Table 1, which misidentified the trial included in the meta-analysis registered as NCT04323527 as CloroCOVID19II instead of CloroCOVID19III. The NCT04323527 registration includes the trials CloroCOVID19I and CloroCOVID19III. CloroCOVID19I was not included in the meta-analysis. In addition, the original version of the Methods section inadvertently omitted details of which formulations of hydroxychloroquine or chloroquine the reported dosages refer to. The following information has been included in the legend for Table 1 and in the corrected methods section: “In all trials that used hydroxychloroquine, dosages refer to hydroxychloroquine sulfate. In trials that used chloroquine, the dosages for ARCHAIC, ChiCTR2000030054 and ChiCTR2000031204 refer to chloroquine phosphate, while those for CloroCOVID19II and CloroCOVID19III refer to chloroquine base. The American Journal of Tropical Medicine and Hygiene has issued a retraction note (1) for one of the trials (2) that had been included in the calculations of our meta-analysis. Exclusion of the data from this trial changes neither the results nor inferences of the meta-analysis. For hydroxychloroquine, the original odds ratio for mortality was 1.11 (95% CI: 1.02–1.20; I ² = 0%; 26 trials; 10,012 patients) and excluding the retracted trial the odds ratio for mortality would remain 1.11 (95% CI: 1.02–1.20, I ² = 0%; 25 trials; 9818 patients). Retraction Notice. The American Journal of Tropical Medicine and Hygiene 107, 728-728, https://doi.org/10.4269/ajtmh.1073ret (2022). Abd-Elsalam, S. et al. RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study. Am J Trop Med Hyg 103, 1635-1639, https://doi.org/10.4269/ajtmh.20-0873 (2020). The errors in Table 1 and in the Methods section have been corrected in both the PDF and HTML versions of the Article.

Original language	English
Article number	1075
Journal	Nature Communications
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/s41467-024-45360-6
Publication status	Published - 5 Feb 2024

Access to Document

10.1038/s41467-024-45360-6Licence: CC BY

s41467-024-45360-6Final published version, 0.99 MBLicence: CC BY

Fingerprint

Dive into the research topics of 'Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)'. Together they form a unique fingerprint.

Cite this

Axfors, C., Schmitt, A. M., Janiaud, P., Van't Hooft, J., Abd-Elsalam, S., Abdo, E. F., Abella, B. S., Akram, J., Amaravadi, R. K., Angus, D. C., Arabi, Y. M., Azhar, S., Baden, L. R., Baker, A. W., Belkhir, L., Benfield, T., Berrevoets, M. A. H., Chen, C.-P., Chen, T.-C., ... Hemkens, L. G. (2024). Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z). Nature Communications, 15(1), Article 1075. https://doi.org/10.1038/s41467-024-45360-6

@article{b326bf4469cf40ae9ea4d3f8927350b4,

title = "Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)",

abstract = "Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-021-22446-z, published online 15 April 2021 The original version of this article contained an error in Table 1, which misidentified the trial included in the meta-analysis registered as NCT04323527 as CloroCOVID19II instead of CloroCOVID19III. The NCT04323527 registration includes the trials CloroCOVID19I and CloroCOVID19III. CloroCOVID19I was not included in the meta-analysis. In addition, the original version of the Methods section inadvertently omitted details of which formulations of hydroxychloroquine or chloroquine the reported dosages refer to. The following information has been included in the legend for Table 1 and in the corrected methods section: “In all trials that used hydroxychloroquine, dosages refer to hydroxychloroquine sulfate. In trials that used chloroquine, the dosages for ARCHAIC, ChiCTR2000030054 and ChiCTR2000031204 refer to chloroquine phosphate, while those for CloroCOVID19II and CloroCOVID19III refer to chloroquine base. The American Journal of Tropical Medicine and Hygiene has issued a retraction note (1) for one of the trials (2) that had been included in the calculations of our meta-analysis. Exclusion of the data from this trial changes neither the results nor inferences of the meta-analysis. For hydroxychloroquine, the original odds ratio for mortality was 1.11 (95% CI: 1.02–1.20; I 2 = 0%; 26 trials; 10,012 patients) and excluding the retracted trial the odds ratio for mortality would remain 1.11 (95% CI: 1.02–1.20, I 2 = 0%; 25 trials; 9818 patients). Retraction Notice. The American Journal of Tropical Medicine and Hygiene 107, 728-728, https://doi.org/10.4269/ajtmh.1073ret (2022). Abd-Elsalam, S. et al. RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study. Am J Trop Med Hyg 103, 1635-1639, https://doi.org/10.4269/ajtmh.20-0873 (2020). The errors in Table 1 and in the Methods section have been corrected in both the PDF and HTML versions of the Article.",

author = "Cathrine Axfors and Schmitt, {Andreas M} and Perrine Janiaud and {Van't Hooft}, Janneke and Sherief Abd-Elsalam and Abdo, {Ehab F} and Abella, {Benjamin S} and Javed Akram and Amaravadi, {Ravi K} and Angus, {Derek C} and Arabi, {Yaseen M} and Shehnoor Azhar and Baden, {Lindsey R} and Baker, {Arthur W} and Leila Belkhir and Thomas Benfield and Berrevoets, {Marvin A H} and Cheng-Pin Chen and Tsung-Chia Chen and Shu-Hsing Cheng and Chien-Yu Cheng and Wei-Sheng Chung and Cohen, {Yehuda Z} and Cowan, {Lisa N} and Olav Dalgard and {de Almeida E Val}, {Fernando F} and {de Lacerda}, {Marcus V G} and {de Melo}, {Gisely C} and Lennie Derde and Vincent Dubee and Anissa Elfakir and Gordon, {Anthony C} and Hernandez-Cardenas, {Carmen M} and Thomas Hills and Hoepelman, {Andy I M} and Yi-Wen Huang and Bruno Igau and Ronghua Jin and Felipe Jurado-Camacho and Khan, {Khalid S} and Kremsner, {Peter G} and Benno Kreuels and Cheng-Yu Kuo and Thuy Le and Yi-Chun Lin and Wu-Pu Lin and Tse-Hung Lin and Lyngbakken, {Magnus Nakrem} and Colin McArthur and McVerry, {Bryan J} and Patricia Meza-Meneses and Monteiro, {Wuelton M} and Morpeth, {Susan C} and Ahmad Mourad and Mulligan, {Mark J} and Srinivas Murthy and Susanna Naggie and Shanti Narayanasamy and Alistair Nichol and Novack, {Lewis A} and O'Brien, {Sean M} and Okeke, {Nwora Lance} and L{\'e}na Perez and Rogelio Perez-Padilla and Laurent Perrin and Arantxa Remigio-Luna and Rivera-Martinez, {Norma E} and Rockhold, {Frank W} and Sebastian Rodriguez-Llamazares and Robert Rolfe and Rossana Rosa and Helge R{\o}sj{\o} and Sampaio, {Vanderson S} and Seto, {Todd B} and Muhammad Shahzad and Shaimaa Soliman and Stout, {Jason E} and Ireri Thirion-Romero and Troxel, {Andrea B} and Ting-Yu Tseng and Turner, {Nicholas A} and Ulrich, {Robert J} and Walsh, {Stephen R} and Webb, {Steve A} and Weehuizen, {Jesper M} and Maria Velinova and Hon-Lai Wong and Rebekah Wrenn and Zampieri, {Fernando G} and Wu Zhong and David Moher and Goodman, {Steven N} and Ioannidis, {John P A} and Hemkens, {Lars G}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = feb,

day = "5",

doi = "10.1038/s41467-024-45360-6",

language = "English",

volume = "15",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

Axfors, C, Schmitt, AM, Janiaud, P, Van't Hooft, J, Abd-Elsalam, S, Abdo, EF, Abella, BS, Akram, J, Amaravadi, RK, Angus, DC, Arabi, YM, Azhar, S, Baden, LR, Baker, AW, Belkhir, L, Benfield, T, Berrevoets, MAH, Chen, C-P, Chen, T-C, Cheng, S-H, Cheng, C-Y, Chung, W-S, Cohen, YZ, Cowan, LN, Dalgard, O, de Almeida E Val, FF, de Lacerda, MVG, de Melo, GC, Derde, L, Dubee, V, Elfakir, A, Gordon, AC, Hernandez-Cardenas, CM, Hills, T, Hoepelman, AIM, Huang, Y-W, Igau, B, Jin, R, Jurado-Camacho, F, Khan, KS, Kremsner, PG, Kreuels, B, Kuo, C-Y, Le, T, Lin, Y-C, Lin, W-P, Lin, T-H, Lyngbakken, MN, McArthur, C, McVerry, BJ, Meza-Meneses, P, Monteiro, WM, Morpeth, SC, Mourad, A, Mulligan, MJ, Murthy, S, Naggie, S, Narayanasamy, S, Nichol, A, Novack, LA, O'Brien, SM, Okeke, NL, Perez, L, Perez-Padilla, R, Perrin, L, Remigio-Luna, A, Rivera-Martinez, NE, Rockhold, FW, Rodriguez-Llamazares, S, Rolfe, R, Rosa, R, Røsjø, H, Sampaio, VS, Seto, TB, Shahzad, M, Soliman, S, Stout, JE, Thirion-Romero, I, Troxel, AB, Tseng, T-Y, Turner, NA, Ulrich, RJ, Walsh, SR, Webb, SA, Weehuizen, JM, Velinova, M, Wong, H-L, Wrenn, R, Zampieri, FG, Zhong, W, Moher, D, Goodman, SN, Ioannidis, JPA & Hemkens, LG 2024, 'Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)', Nature Communications, vol. 15, no. 1, 1075. https://doi.org/10.1038/s41467-024-45360-6

Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z). / Axfors, Cathrine; Schmitt, Andreas M; Janiaud, Perrine et al.
In: Nature Communications, Vol. 15, No. 1, 1075, 05.02.2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Author Correction 2024

T2 - Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

AU - Axfors, Cathrine

AU - Schmitt, Andreas M

AU - Janiaud, Perrine

AU - Van't Hooft, Janneke

AU - Abd-Elsalam, Sherief

AU - Abdo, Ehab F

AU - Abella, Benjamin S

AU - Akram, Javed

AU - Amaravadi, Ravi K

AU - Angus, Derek C

AU - Arabi, Yaseen M

AU - Azhar, Shehnoor

AU - Baden, Lindsey R

AU - Baker, Arthur W

AU - Belkhir, Leila

AU - Benfield, Thomas

AU - Berrevoets, Marvin A H

AU - Chen, Cheng-Pin

AU - Chen, Tsung-Chia

AU - Cheng, Shu-Hsing

AU - Cheng, Chien-Yu

AU - Chung, Wei-Sheng

AU - Cohen, Yehuda Z

AU - Cowan, Lisa N

AU - Dalgard, Olav

AU - de Almeida E Val, Fernando F

AU - de Lacerda, Marcus V G

AU - de Melo, Gisely C

AU - Derde, Lennie

AU - Dubee, Vincent

AU - Elfakir, Anissa

AU - Gordon, Anthony C

AU - Hernandez-Cardenas, Carmen M

AU - Hills, Thomas

AU - Hoepelman, Andy I M

AU - Huang, Yi-Wen

AU - Igau, Bruno

AU - Jin, Ronghua

AU - Jurado-Camacho, Felipe

AU - Khan, Khalid S

AU - Kremsner, Peter G

AU - Kreuels, Benno

AU - Kuo, Cheng-Yu

AU - Le, Thuy

AU - Lin, Yi-Chun

AU - Lin, Wu-Pu

AU - Lin, Tse-Hung

AU - Lyngbakken, Magnus Nakrem

AU - McArthur, Colin

AU - McVerry, Bryan J

AU - Meza-Meneses, Patricia

AU - Monteiro, Wuelton M

AU - Morpeth, Susan C

AU - Mourad, Ahmad

AU - Mulligan, Mark J

AU - Murthy, Srinivas

AU - Naggie, Susanna

AU - Narayanasamy, Shanti

AU - Nichol, Alistair

AU - Novack, Lewis A

AU - O'Brien, Sean M

AU - Okeke, Nwora Lance

AU - Perez, Léna

AU - Perez-Padilla, Rogelio

AU - Perrin, Laurent

AU - Remigio-Luna, Arantxa

AU - Rivera-Martinez, Norma E

AU - Rockhold, Frank W

AU - Rodriguez-Llamazares, Sebastian

AU - Rolfe, Robert

AU - Rosa, Rossana

AU - Røsjø, Helge

AU - Sampaio, Vanderson S

AU - Seto, Todd B

AU - Shahzad, Muhammad

AU - Soliman, Shaimaa

AU - Stout, Jason E

AU - Thirion-Romero, Ireri

AU - Troxel, Andrea B

AU - Tseng, Ting-Yu

AU - Turner, Nicholas A

AU - Ulrich, Robert J

AU - Walsh, Stephen R

AU - Webb, Steve A

AU - Weehuizen, Jesper M

AU - Velinova, Maria

AU - Wong, Hon-Lai

AU - Wrenn, Rebekah

AU - Zampieri, Fernando G

AU - Zhong, Wu

AU - Moher, David

AU - Goodman, Steven N

AU - Ioannidis, John P A

AU - Hemkens, Lars G

PY - 2024/2/5

Y1 - 2024/2/5

N2 - Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-021-22446-z, published online 15 April 2021 The original version of this article contained an error in Table 1, which misidentified the trial included in the meta-analysis registered as NCT04323527 as CloroCOVID19II instead of CloroCOVID19III. The NCT04323527 registration includes the trials CloroCOVID19I and CloroCOVID19III. CloroCOVID19I was not included in the meta-analysis. In addition, the original version of the Methods section inadvertently omitted details of which formulations of hydroxychloroquine or chloroquine the reported dosages refer to. The following information has been included in the legend for Table 1 and in the corrected methods section: “In all trials that used hydroxychloroquine, dosages refer to hydroxychloroquine sulfate. In trials that used chloroquine, the dosages for ARCHAIC, ChiCTR2000030054 and ChiCTR2000031204 refer to chloroquine phosphate, while those for CloroCOVID19II and CloroCOVID19III refer to chloroquine base. The American Journal of Tropical Medicine and Hygiene has issued a retraction note (1) for one of the trials (2) that had been included in the calculations of our meta-analysis. Exclusion of the data from this trial changes neither the results nor inferences of the meta-analysis. For hydroxychloroquine, the original odds ratio for mortality was 1.11 (95% CI: 1.02–1.20; I 2 = 0%; 26 trials; 10,012 patients) and excluding the retracted trial the odds ratio for mortality would remain 1.11 (95% CI: 1.02–1.20, I 2 = 0%; 25 trials; 9818 patients). Retraction Notice. The American Journal of Tropical Medicine and Hygiene 107, 728-728, https://doi.org/10.4269/ajtmh.1073ret (2022). Abd-Elsalam, S. et al. RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study. Am J Trop Med Hyg 103, 1635-1639, https://doi.org/10.4269/ajtmh.20-0873 (2020). The errors in Table 1 and in the Methods section have been corrected in both the PDF and HTML versions of the Article.

AB - Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-021-22446-z, published online 15 April 2021 The original version of this article contained an error in Table 1, which misidentified the trial included in the meta-analysis registered as NCT04323527 as CloroCOVID19II instead of CloroCOVID19III. The NCT04323527 registration includes the trials CloroCOVID19I and CloroCOVID19III. CloroCOVID19I was not included in the meta-analysis. In addition, the original version of the Methods section inadvertently omitted details of which formulations of hydroxychloroquine or chloroquine the reported dosages refer to. The following information has been included in the legend for Table 1 and in the corrected methods section: “In all trials that used hydroxychloroquine, dosages refer to hydroxychloroquine sulfate. In trials that used chloroquine, the dosages for ARCHAIC, ChiCTR2000030054 and ChiCTR2000031204 refer to chloroquine phosphate, while those for CloroCOVID19II and CloroCOVID19III refer to chloroquine base. The American Journal of Tropical Medicine and Hygiene has issued a retraction note (1) for one of the trials (2) that had been included in the calculations of our meta-analysis. Exclusion of the data from this trial changes neither the results nor inferences of the meta-analysis. For hydroxychloroquine, the original odds ratio for mortality was 1.11 (95% CI: 1.02–1.20; I 2 = 0%; 26 trials; 10,012 patients) and excluding the retracted trial the odds ratio for mortality would remain 1.11 (95% CI: 1.02–1.20, I 2 = 0%; 25 trials; 9818 patients). Retraction Notice. The American Journal of Tropical Medicine and Hygiene 107, 728-728, https://doi.org/10.4269/ajtmh.1073ret (2022). Abd-Elsalam, S. et al. RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study. Am J Trop Med Hyg 103, 1635-1639, https://doi.org/10.4269/ajtmh.20-0873 (2020). The errors in Table 1 and in the Methods section have been corrected in both the PDF and HTML versions of the Article.

UR - http://www.scopus.com/inward/record.url?scp=85184728252&partnerID=8YFLogxK

U2 - 10.1038/s41467-024-45360-6

DO - 10.1038/s41467-024-45360-6

M3 - Comment/Letter to the editor

C2 - 38316844

SN - 2041-1723

VL - 15

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 1075

ER -

Axfors C, Schmitt AM, Janiaud P, Van't Hooft J, Abd-Elsalam S, Abdo EF et al. Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z). Nature Communications. 2024 Feb 5;15(1):1075. doi: 10.1038/s41467-024-45360-6

Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this